QuintilesIMS eyes revenue growth with refinancing

By Melissa Fassbender contact

- Last updated on GMT

QuintilesIMS eyes revenue growth with refinancing

Related tags: Stock

QuintilesIMS has announced an offering of senior notes and a proposed debt refinancing as leadership looks to drive revenue growth, according to a Jefferies analyst.

Yesterday, Quintiles IMS Holdings, Inc. announced​ that its subsidiary, Quintiles IMS Incorporated plans to raise €850m ($900.41m) in gross proceeds through a senior note offering due 2025.

The company is also planning to refinance its loans.

David H Windley, Healthcare Equity Research at Jefferies LLC told us “The new leadership team is propping up EPS growth with cost cuts and share buybacks to offset slowing revenue growth​.”

According to the press release, “The net proceeds from the notes offering and the refinancing will be used to refinance certain indebtedness of the Issuer, to pay fees and expenses related to the notes offering and the refinancing and for other general corporate purposes, which may include share repurchases, including the repurchase of shares from affiliates and significant shareholders, and future acquisitions​.”

In November of last year, the contract research organization (CRO) announced​ its acquisition of TKL Research’s Clinical Trials Division. The acquisition followed its merger with IMS Health​, which was completed in October 2016.

QuintilesIMS did not respond to a request for comment.

(Features image: iStock/BernardaSv)

Related news

Show more

Related products

show more

How clinical trial software can optimize trials

How clinical trial software can optimize trials

Formedix | 20-Jun-2022 | Technical / White Paper

This article explains the different types of clinical trial software available, and how it can be used to optimize the end to end clinical trials design...

Strategic Approach to Immunogenicity Assessment

Strategic Approach to Immunogenicity Assessment

Altasciences | 17-May-2022 | Technical / White Paper

In this issue of The Altascientist we provide a detailed overview on the different goals and challenges that are presented by the validation of immunogenicity...

Governing and Maintaining Clinical Data Standards

Governing and Maintaining Clinical Data Standards

Veeva | 10-May-2022 | Technical / White Paper

Investing in data standards plays a huge role in improving the quality of clinical studies. But often, people don’t use the standards correctly, there...

Related suppliers

Follow us

Products

View more

Webinars